• Gimv invests in the German Ambulantis Group, a fast-growing care provider with a focus on outpatient care in assisted living facilities and day care.

• The company currently employs more than 500 people and operates in 6 cities in northern and eastern Germany, in some cases with multiple locations.

• This transaction is part of a growth plan with the company’s founders and managing directors, Dr. Stefan Buchkremer, Richard Simm and Dr. Matthias Weber, continuing to be key shareholders of the company.

Ambulantis (www.ambulantis.de) is committed to enabling people in need of care to lead a fulfilling life in their own home or shared apartment. To this end, the company offers nursing care including outpatient care, day care, care in assisted living facilities and residential care communities. Its approach enables customers to maintain a high degree of privacy and independence while benefiting from nursing care tailored to their individual needs. In addition, the Ambulantis concept promotes social interaction and participation in society through numerous joint activities.

Ambulantis fosters a value-oriented corporate culture based on appreciation, care and participation. The intensive and diverse engagement of the company’s employees leads to a high level of employee satisfaction across all locations.

“We are convinced that Gimv’s experience in building and scaling healthcare providers makes it the ideal partner to help us realize the company’s growth ambitions and expand Ambulantis’ presence in Germany,” declare Dr. Stefan Buchkremer, Richard Simm and Dr. Matthias Weber, Managing Partners of Ambulantis.

“Ambulantis has a focused and proven concept that serves the preferences of clients and relatives as well as caregivers. Thanks to Ambulantis’ clear commitment to quality, its skilled and motivated staff and its highly structured and scalable processes, we are convinced that Ambulantis is the right platform to build a leading provider of comprehensive care services in assisted living facilities in Germany. We are excited to supporting the management and the entire Ambulantis team in realizing their ambitious growth plans, ” explain Philipp v. Hammerstein and Lars Timmer, Partner and Senior Principal specializing in healthcare in the Munich office of Gimv.

Gimv will hold a significant stake in Ambulantis and will support Dr. Stefan Buchkremer, Richard Simm and Dr. Matthias Weber in the further development of the group. The transaction is still subject to the usual regulatory approval and is expected to be completed in the coming weeks.